CryoPatch SG Pulmonary Hemi-Artery, 1 graft
FDA Device Recall #Z-0121-2019 — Class II — September 6, 2018
Recall Summary
| Recall Number | Z-0121-2019 |
| Classification | Class II — Moderate risk |
| Date Initiated | September 6, 2018 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | CryoLife, Inc. |
| Location | Kennesaw, GA |
| Product Type | Devices |
| Quantity | 1 graft |
Product Description
CryoPatch SG Pulmonary Hemi-Artery, 1 graft
Reason for Recall
The conduit length and branch length of a SG Pulmonary Hemi-Artery were switched on the product labeling. The graft labeling indicates the conduit length is 1.0cm and the branch length is 4.5cm.
Distribution Pattern
US Nationwide in the state of California.
Lot / Code Information
Model Number SGPH00, Serial Number 10978889, Lot Number 144125, Expiration Date 05/16/2022
Other Recalls from CryoLife, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0384-2022 | Class II | BioGlue Surgical Adhesive, Model BG3510-5-G | Oct 7, 2021 |
| Z-0653-2021 | Class II | CryoPatch SG Pulmonary Human Cardiac Patch. Th... | Nov 10, 2020 |
| Z-0652-2021 | Class II | CryoValve SG Pulmonary Human Heart Valve. The ... | Nov 10, 2020 |
| Z-1073-2019 | Class II | On-X Aortic Heart Valve with Anatomic Sewing Ri... | Jan 17, 2019 |
| Z-2556-2018 | Class II | BioGlue Spreader Tip, 12mm, Sterile, RX Only. ... | Jun 4, 2018 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.